ExodusPoint Capital Management LP Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)

ExodusPoint Capital Management LP boosted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 167.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,810 shares of the company's stock after purchasing an additional 34,340 shares during the period. ExodusPoint Capital Management LP's holdings in Option Care Health were worth $1,272,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. increased its position in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after acquiring an additional 1,005 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after purchasing an additional 681 shares during the period. Finally, Venturi Wealth Management LLC grew its stake in shares of Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after purchasing an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

OPCH has been the topic of several recent research reports. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Barrington Research lifted their price objective on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Stock Down 0.1 %

OPCH stock traded down $0.04 during trading on Monday, reaching $31.51. 2,538,578 shares of the stock were exchanged, compared to its average volume of 1,781,077. The firm's 50 day moving average is $33.24 and its 200 day moving average is $28.58. The firm has a market cap of $5.18 billion, a P/E ratio of 26.48, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.